Atlas Trials

Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder

Clinical trial NCT03558919 · COMPLETED

Trial details

NCT number
NCT03558919
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Overactive Bladder
Start date
2017-01-01
Primary completion
2017-12-30
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.